All Relations between Stroke and ci

Publication Sentence Publish Date Extraction Date Species
Kazunori Toyoda, Shinichiro Uchiyama, Yasushi Hagihara, Takahiro Kuwashiro, Takahisa Mori, Kenji Kamiyama, Yasuhisa Urano, Atsushi Taniguchi, Kenma Nozaki, Lisa Cronin, Claudia Grauer, Martina Brueckmann, Hans-Christoph Diene. Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source - Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial. Circulation journal : official journal of the Japanese Circulation Society. vol 84. issue 12. 2021-05-11. PMID:33132228. in contrast, in the non-japanese cohort, recurrent stroke occurred in 4.1%/year and 4.3%/year, respectively, showing no apparent difference in recurrent stroke for dabigatran vs. aspirin (hr, 0.91; 95% ci, 0.74-1.14). 2021-05-11 2023-08-13 Not clear
Vien T Truong, Satya Shreenivas, Wojciech Mazur, Gregory F Egnaczyk, Cassady Palmer, Sriram D Rao, J Eduardo Rame, Eugene S Chun. Left Ventricular End-Diastolic Dimension and Clinical Outcomes After Centrifugal Flow Left Ventricular Assist Device Implantation. ASAIO journal (American Society for Artificial Internal Organs : 1992). 2021-04-30. PMID:33927084. after adjusting for significant covariates, increased prelvedd was associated with lower mortality (hazard ratio [hr], 0.91; 95% confidence interval [ci], 0.84-0.98; p = 0.01), stroke (hr, 0.85; 95% ci, 0.77-0.93; p < 0.001), and gastrointestinal bleeding (hr, 0.88; 95% ci, 0.80-0.97; p = 0.01), although there were more arrhythmias (hr, 1.14; 95% ci, 1.05-1.24; p = 0.003). 2021-04-30 2023-08-13 Not clear
Ahmad Jayedi, Sakineh Shab-Bida. Fish Consumption and the Risk of Chronic Disease: An Umbrella Review of Meta-Analyses of Prospective Cohort Studies. Advances in nutrition (Bethesda, Md.). vol 11. issue 5. 2021-04-28. PMID:32207773. moderate-quality evidence suggested that each 100-g/d increment in fish consumption was associated with a lower risk of all-cause mortality (srr: 0.92; 95% ci: 0.87, 0.97), cardiovascular mortality (srr: 0.75; 95% ci: 0.65, 0.87), coronary heart disease (srr: 0.88; 95% ci: 0.79, 0.99), myocardial infarction (srr: 0.75; 95% ci: 0.65, 0.93), stroke (srr: 0.86; 95% ci: 0.75, 0.99), heart failure (srr: 0.80; 95% ci: 0.67, 0.95), depression (srr: 0.88; 95% ci: 0.79, 0.98), and liver cancer (srr: 0.65; 95% ci: 0.48, 0.87). 2021-04-28 2023-08-13 Not clear
Abdullah Al-Abcha, Yehia Saleh, Manel Boumegouas, Rohan Prasad, Khader Herzallah, Zulfiqar Qutrio Baloch, Ola Abdelkarim, Supratik Rayamajhi, George S Abel. Meta-Analysis of Valve-in-Valve Transcatheter Aortic Valve Implantation Versus Redo-surgical Aortic Valve Replacement in Failed Bioprosthetic Aortic Valve. The American journal of cardiology. vol 146. 2021-04-26. PMID:33529615. the rate of major bleeding (or 0.36; 95% ci 0.16 to 0.83, p = 0.02), procedural mortality (or 0.41; 95% ci 0.18 to 0.96, p = 0.04), 30-day mortality (or 0.58; 95% ci 0.45 to 0.74, p <0.0001), and the rate of stroke (or 0.65; 95% ci 0.52 to 0.81, p = 0.0001) were significantly lower in the viv- tavi arm when compared with redo-savr arm. 2021-04-26 2023-08-13 Not clear
Mihir Dave, Ashish Kumar, Monil Majmundar, Devina Adalja, Mariam Shariff, Palak Shah, Rupak Desai, Krunalkumar Patel, Gowthami Sai Kogilathota Jagirdhar, Saraschandra Vallabhajosyula, Nageshwara Gullapalli, Rajkumar Dosh. Frequency, Trend, Predictors, and Impact of Gastrointestinal Bleeding in Atrial Fibrillation Hospitalizations. The American journal of cardiology. vol 146. 2021-04-26. PMID:33529616. af hospitalizations with gib had a lower odds of stroke (or 0.51; 95% ci: 0.51 to 0.52, p-value <0.0001) compared with af hospitalizations without gib. 2021-04-26 2023-08-13 Not clear
Yousif Ahmad, James P Howar. Meta-Analysis of Usefulness of Cerebral Embolic Protection During Transcatheter Aortic Valve Implantation. The American journal of cardiology. vol 146. 2021-04-26. PMID:33556360. the risk of stroke was not significantly different with the use of cerebral embolic protection: relative risk (rr) 0.88, 95% confidence interval (ci) 0.57 to 1.36, p = 0.566. 2021-04-26 2023-08-13 Not clear
John E Anderson, Eugene E Wright, Charles F Shaefe. Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus. Diabetes therapy : research, treatment and education of diabetes and related disorders. vol 8. issue 1. 2021-04-20. PMID:27837465. the risk of major adverse cv events (mace: first occurrence of cv death, non-fatal myocardial infarction, or non-fatal stroke) was reduced by 14% relative to placebo (hr 0.86; 95.02% ci: 0.74-0.99; p = 0.04 for superiority). 2021-04-20 2023-08-13 Not clear
Hong Chuan Loh, Renly Lim, Kai Wei Lee, Chin Yik Ooi, Deik Roy Chuan, Irene Looi, Yuen Kah Hay, Nurzalina Abdul Karim Kha. Effects of vitamin E on stroke: a systematic review with meta-analysis and trial sequential analysis. Stroke and vascular neurology. vol 6. issue 1. 2021-04-16. PMID:33109618. there was no significant difference in the prevention of total stroke (rr (relative risk)=0.98, 95% ci 0.92-1.04, p=0.57), fatal stroke (rr=0.96, 95% ci 0.77-1.20, p=0.73) and non-fatal stroke (rr=0.96, 95% ci 0.88-1.05, p=0.35). 2021-04-16 2023-08-13 human
Hong Chuan Loh, Renly Lim, Kai Wei Lee, Chin Yik Ooi, Deik Roy Chuan, Irene Looi, Yuen Kah Hay, Nurzalina Abdul Karim Kha. Effects of vitamin E on stroke: a systematic review with meta-analysis and trial sequential analysis. Stroke and vascular neurology. vol 6. issue 1. 2021-04-16. PMID:33109618. in stroke subtypes analysis, vitamin e showed significant risk reduction in ischaemic stroke (rr=0.92, 95% ci 0.85-0.99, p=0.04) but not in haemorrhagic stroke (rr=1.17, 95% ci 0.98-1.39, p=0.08). 2021-04-16 2023-08-13 human
Yukiko Matsumura-Nakano, Hiroki Shiomi, Takeshi Morimoto, Kyohei Yamaji, Natsuhiko Ehara, Hiroki Sakamoto, Yasuaki Takeji, Yusuke Yoshikawa, Ko Yamamoto, Kazuaki Imada, Takeshi Tada, Ryoji Taniguchi, Ryusuke Nishikawa, Tomohisa Tada, Takashi Uegaito, Tatsuya Ogawa, Miho Yamada, Teruki Takeda, Hiroshi Eizawa, Nobushige Tamura, Keiichi Tambara, Satoru Suwa, Manabu Shirotani, Toshihiro Tamura, Moriaki Inoko, Junichiro Nishizawa, Masahiro Natsuaki, Hiroshi Sakai, Takashi Yamamoto, Naoki Kanemitsu, Nobuhisa Ohno, Katsuhisa Ishii, Akira Marui, Hiroshi Tsuneyoshi, Yasuhiko Terai, Shogo Nakayama, Kazuhiro Yamazaki, Mamoru Takahashi, Takashi Tamura, Jiro Esaki, Shinji Miki, Tomoya Onodera, Hiroshi Mabuchi, Yutaka Furukawa, Masaru Tanaka, Tatsuhiko Komiya, Yoshiharu Soga, Michiya Hanyu, Kenji Ando, Kazushige Kadota, Kenji Minatoya, Yoshihisa Nakagawa, Takeshi Kimur. Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3). The American journal of cardiology. vol 145. 2021-04-16. PMID:33454340. there was significant excess risk of pci relative to cabg for myocardial infarction (hr, 1.77; 95% ci, 1.19 to 2.69; p = 0.006), whereas there was no excess risk of pci relative to cabg for stroke (hr, 1.24; 95% ci, 0.83 to 1.88; p = 0.30). 2021-04-16 2023-08-13 Not clear
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Kazushige Kadota, Tomohisa Tada, Yasuaki Takeji, Yukiko Matsumura-Nakano, Yusuke Yoshikawa, Kazuaki Imada, Takenori Domei, Kazuhisa Kaneda, Ryoji Taniguchi, Natsuhiko Ehara, Ryuzo Nawada, Masahiro Natsuaki, Kyohei Yamaji, Mamoru Toyofuku, Naoki Kanemitsu, Eiji Shinoda, Satoru Suwa, Atsushi Iwakura, Toshihiro Tamura, Yoshiharu Soga, Tsukasa Inada, Mitsuo Matsuda, Tadaaki Koyama, Takeshi Aoyama, Yukihito Sato, Yutaka Furukawa, Kenji Ando, Fumio Yamazaki, Tatsuhiko Komiya, Kenji Minatoya, Yoshihisa Nakagawa, Takeshi Kimur. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3). The American journal of cardiology. vol 145. 2021-04-16. PMID:33454345. there were significant excess risks of pci relative to cabg for myocardial infarction and any coronary revascularization (hr, 2.07; 95% ci, 1.30 to 3.37; p = 0.002, and hr, 2.96; 95% ci, 1.96 to 4.46; p < 0.001), whereas there was no significant excess risk of pci relative to cabg for stroke (hr, 0.85; 95% ci, 0.50 to 1.41; p = 0.52). 2021-04-16 2023-08-13 Not clear
Waqas Ullah, Mohamed Zghouzi, Bachar Ahmad, Suman Biswas, Nathan Zaher, Yasar Sattar, Homam Moussa Pacha, Andrew M Goldsweig, Poonam Velagapudi, David L Fichman, Anand Prasad, M Chadi Alraie. Meta-Analysis Comparing the Safety and Efficacy of Single vs Dual Antiplatelet Therapy in Post Transcatheter Aortic Valve Implantation Patients. The American journal of cardiology. vol 145. 2021-04-16. PMID:33454348. these was no significant difference in the odds of varc-2 life threatening bleeding (or 0.52, 95% ci 0.25 to 1.07, p = 0.08), prosthetic valve thrombosis (or 1.17, 95% ci 0.22 to 6.30, p = 0.85), cardiac tamponade (or 0.77, 95% ci 0.20 to 2.98, p = 0.70), conversion to open procedure (or 1.99, 95 % ci 0.42 to 9.44, p = 0.39), mi (or 0.79 95% ci 0.38 to 1.64, p = 0.52), transient ischemic attack (tia) (or 0.89, 95% ci 0.12 to 6.44, p = 0.91), major stroke (or 0.68 95 % ci 0.43 to 1.08, p = 0.10), disabling stroke (0r 1.01, 95% ci 0.41 to 2.48, p = 0.99), cardiovascular mortality (or 0.81 95% ci 0.38 to 1.74, p = 0.59) and all-cause mortality (or 0.86, 95% ci 0.63 to 1.16, p = 0.31) between the 2 groups. 2021-04-16 2023-08-13 Not clear
Homam Moussa Pacha, Yasser Al-Khadra, Fahed Darmoch, Mohamad Soud, Chun Shing Kwok, Mamas A Mamas, Said Ashraf, Yasar Sattar, Waqas Ullah, Subhash Banerjee, Salman A Arain, Dmitriy N Feldman, Mazen Abu-Fadel, Herbert D Aronow, Mehdi H Shishehbor, M Chadi Alraie. In-Hospital Outcomes and Trends of Endovascular Intervention vs Surgical Revascularization in Octogenarians With Peripheral Artery Disease. The American journal of cardiology. vol 145. 2021-04-16. PMID:33460607. evi group had lower odds of in-hospital mortality (adjusted odds ratio [aor]: 0.61 [95% ci: 0.58 to 0.63], myocardial infarction (aor: 0.84 [95% ci: 0.81 to 0.87]), stroke (aor: 0.93 [95% ci: 0.89 to 0.96]), acute kidney injury (aor: 0.79 [95% ci: 0.77 to 0.81]), and limb amputation (aor: 0.77 [95% ci: 0.74 to 0.79]) compared with surgical group (p < 0.001 for all). 2021-04-16 2023-08-13 Not clear
Wen Xiuyun, Wu Qian, Xie Minjun, Li Weidong, Liao Lizhe. Education and stroke: evidence from epidemiology and Mendelian randomization study. Scientific reports. vol 10. issue 1. 2021-04-14. PMID:33273579. participants with advanced education level were associated with 25% (hr 0.75; 95% ci 0.62, 0.91) decreased the rate of incident total stroke. 2021-04-14 2023-08-13 human
Brandon M Jones, Vishesh Kumar, Shih Ting Chiu, Ethan Korngold, Robert W Hodson, Kateri J Spinelli, Eric B Kirke. Comparable Outcomes for Transcarotid and Transfemoral Transcatheter Aortic Valve Replacement at a High Volume US Center. Seminars in thoracic and cardiovascular surgery. 2021-04-08. PMID:33713830. psw 30-day stroke (odds ratio (or) (95% confidence interval (ci)) = 0.8 (0.2-2.8)) and mortality (or (95% ci) = 0.8 (0.2-3.0)) were similar between groups. 2021-04-08 2023-08-13 Not clear
Mengyun Huang, Lijun Zhu, Yan Chen, Yuelong Jin, Zhengmei Fang, Yingshui Ya. Serum/Plasma Zinc Is Apparently Increased in Ischemic Stroke: a Meta-analysis. Biological trace element research. 2021-04-07. PMID:33825164. overall, the meta-analysis demonstrated no significant difference in zn levels between the stroke group and control group (smd =-0.18, 95% ci =-0.69 to 0.32, p = 0.480). 2021-04-07 2023-08-13 Not clear
Xiao Liu, Linjuan Guo, Kaiwen Xiao, Wengen Zhu, Menglu Liu, Rong Wan, Kui Hon. The obesity paradox for outcomes in atrial fibrillation: Evidence from an exposure-effect analysis of prospective studies. Obesity reviews : an official journal of the International Association for the Study of Obesity. vol 21. issue 3. 2021-04-05. PMID:31849187. in exposure-effect analysis, the risk per 5 bmi increase was reduced for adverse outcomes (rr=0.86, 95% ci: 0.80-0.92 for all-cause death; rr=0.82, 95% ci: 0.71-0.95 for cardiovascular death; rr=0.89, 95% ci: 0.84-0.95 for stroke or systemic embolism; and rr=0.78, 95% ci: 0.67-0.92 for a composite endpoint). 2021-04-05 2023-08-13 Not clear
Siegal Sadetzki, Angela Chetrit, Ben Boursi, Osnat Luxenburg, Ilya Novikov, Arnon Cohe. Childhood Exposure to Low to Moderate Doses of Ionizing Radiation and the Risk of Vascular Diseases. American journal of epidemiology. vol 190. issue 3. 2021-04-02. PMID:32997139. adjusted for age, sex, socioeconomic status, smoking, hypertension, and diabetes, exposure to ir increased the risk of developing any vascular diseases (relative risk (rr) = 1.19, 95% confidence interval (ci): 1.09, 1.29), stroke (rr = 1.35, 1.20, 1.53), carotid artery stenosis (rr = 1.32, 1.06, 1.64), and ischemic heart disease (rr = 1.12, 1.01, 1.26). 2021-04-02 2023-08-13 Not clear
Sae Young Jae, Kevin Heffernan, Sudhir Kurl, Setor K Kunutsor, Barry A Franklin, Kai Savonen, Jari A Laukkane. Chronotropic Response to Exercise Testing and the Risk of Stroke. The American journal of cardiology. vol 143. 2021-04-02. PMID:33347840. comparing the bottom versus top quintile of chronotropic reserve, there was an increased risk of stroke (hazard ratio [hr] 1.73, 95% confidence interval [ci]: 1.09 to 2.75) and ischemic stroke (hr 1.72, 95% ci, 1.04 to 2.85), but not hemorrhagic stroke (hr 2.23, 95% ci, 0.77 to 6.46) in analyses that adjusted for potential risk factors. 2021-04-02 2023-08-13 Not clear
Waqas Ullah, Salman Zahid, Ihab Hamzeh, Yochai Birnbaum, Salim S Virani, Mahboob Ala. Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From the National Inpatient Sample Database). The American journal of cardiology. vol 143. 2021-04-02. PMID:33359229. the non-survivors had significantly higher adjusted odds of renal failure requiring hemodialysis (aor 2.59, 95% ci 2.24 to 2.99, p ≤ 0.0001), history of mediastinal radiation (aor 2.71, 95% ci 1.02 to 7.20, p = 0.05), liver disease (aor 3.04, 95% ci 2.63 to 3.51, p ≤ 0.0001), pneumonia (aor 2.47, 95% ci 2.15 to 2.83, p ≤ 0.0001), cardiogenic shock (aor 9.83, 95% ci 8.93 to 10.82, p ≤ 0.0001), ventricular tachycardia (aor 2.12, 95% ci 1.88 to 2.40, p ≤ 0.0001), acute st-elevation myocardial infarction (aor 7.38, 95% ci 5.53 to 9.84, p ≤ 0.0001), stroke (aor 2.25, 95% ci 1.99 to 2.54, p ≤ 0.0001), and acute infective endocarditis (aor 5.74, 95% ci 3.65 to 9.02, p ≤ 0.0001) compared to tavi-survivors. 2021-04-02 2023-08-13 Not clear